This document explores the development and usage of Protected Cell Companies (PCCs) and Incorporated Cell Companies (ICCs) in corporate finance, particularly in insurance and banking. It discusses the benefits of PCCs, their legal enforceability, and their role in the insurance market post-9/11. The paper also covers the potential future applications of PCCs and ICCs in risk financing and corporate restructuring.
documents/EFTA01115304.pdf
{}